Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Gains from Investment Securities: 2020-2025

Historic Gains from Investment Securities for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to -$334,000.

  • Maravai Lifesciences Holdings' Gains from Investment Securities fell 67.00% to -$334,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year decrease of 523.47%. This contributed to the annual value of -$2.0 million for FY2024, which is 106.10% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Gains from Investment Securities stood at -$334,000 for Q3 2025, which was down 338.57% from $140,000 recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Gains from Investment Securities peaked at $22.6 million during Q4 2021, and registered a low of -$7.8 million during Q1 2022.
  • For the 3-year period, Maravai Lifesciences Holdings' Gains from Investment Securities averaged around $1.2 million, with its median value being -$211,500 (2024).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first spiked by 2,201.11% in 2021, then plummeted by 2,700.00% in 2022.
  • Over the past 5 years, Maravai Lifesciences Holdings' Gains from Investment Securities (Quarterly) stood at $22.6 million in 2021, then slumped by 84.76% to $3.5 million in 2022, then plummeted by 66.40% to $2.4 million in 2023, then tumbled by 108.39% to -$3.3 million in 2024, then plummeted by 67.00% to -$334,000 in 2025.
  • Its Gains from Investment Securities was -$334,000 in Q3 2025, compared to $140,000 in Q2 2025 and $236,000 in Q1 2025.